GlassScriptPhysician profile
Judith Israel
NPI 1104093806
$4,444.62
in general payments reported to CMS, 2019-2025
8 companies · $813 in 2025
The $813 reported for 2025 was more than what a typical Psychiatric/Mental Health (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $244).
See the full distribution for Psychiatric/Mental Health (Clinical Nurse Specialist)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $696 · 2022: $1,082 · 2023: $902 · 2024: $952 · 2025: $813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,538 · Education: $129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,537.93 |
| Education | $128.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,520.55 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $959.57 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Abbvie INC. | $852.46 | 2021-2024 | |
| Vanda Pharmaceuticals INC. | $351.75 | 2024-2025 | Fanapt |
| Takeda Pharmaceuticals U.S.A., INC. | $264.57 | 2021 | |
| Lundbeck LLC | $240.89 | 2021-2024 | Rexulti |
| Neurocrine Biosciences, INC. | $238.91 | 2022 | |
| Corium, LLC | $15.92 | 2024 | Azstarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Israel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.